BeOne Medicines (ONC) Director Shalini Sharp Receives 18,980-Share Award

What Happened

• Shalini Sharp, a director of BeOne Medicines Ltd. (ONC), received an award of 18,980 shares on 2026-06-11. The grant was reported as an acquisition with a $0.00 purchase price (typical for restricted share unit awards).

Key Details

• Transaction date: 2026-06-11; Form 4 filed: 2026-06-15 (filed within the typical SEC two-business-day window).
• Number of shares/units granted: 18,980 restricted share units; acquisition price: $0.00; total cash paid: $0.
• Shares owned after transaction: Not specified in the filing.
• Footnote F1: These are restricted share units (RSUs). They vest on the earlier of the first anniversary of the grant or the next annual general meeting, but vesting stops if the director resigns unless accelerated under the company’s Independent Non-Executive Director Compensation Policy.
• Footnote F2: Each American Depositary Share (ADS) represents 13 ordinary shares (relevant if the grant is reported in ADS form).

Context

• This was a grant/award (not a buy or sell), so it doesn’t reflect an immediate cash investment or disposition by the director. Grants are commonly part of director compensation and are generally intended to align interests with shareholders rather than signal near-term trading intent.